These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 27331911)

  • 21. Activity-lipophilicity relationship studies on P-gp ligands designed as simplified tariquidar bulky fragments.
    Contino M; Zinzi L; Cantore M; Perrone MG; Leopoldo M; Berardi F; Perrone R; Colabufo NA
    Bioorg Med Chem Lett; 2013 Jul; 23(13):3728-31. PubMed ID: 23726026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, synthesis and structure-activity relationship of novel inhibitors against H5N1 hemagglutinin-mediated membrane fusion.
    Zhu Z; Li R; Xiao G; Chen Z; Yang J; Zhu Q; Liu S
    Eur J Med Chem; 2012 Nov; 57():211-6. PubMed ID: 23059548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis, structure-activity relationship, and pharmacological studies of novel melanin-concentrating hormone receptor 1 antagonists 3-aminomethylquinolines: reducing human ether-a-go-go-related gene (hERG) associated liabilities.
    Kasai S; Kamata M; Masada S; Kunitomo J; Kamaura M; Okawa T; Takami K; Ogino H; Nakano Y; Ashina S; Watanabe K; Kaisho T; Imai YN; Ryu S; Nakayama M; Nagisa Y; Takekawa S; Kato K; Murata T; Suzuki N; Ishihara Y
    J Med Chem; 2012 May; 55(9):4336-51. PubMed ID: 22490048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis and biological evaluation of novel pyrimidine, 3-cyanopyridine and m-amino-N-phenylbenzamide based monocyclic EGFR tyrosine kinase inhibitors.
    Mao Y; Zhu W; Kong X; Wang Z; Xie H; Ding J; Terrett NK; Shen J; Shen J
    Bioorg Med Chem; 2013 Jun; 21(11):3090-104. PubMed ID: 23602524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis, and biological activity of a novel series of human sirtuin-2-selective inhibitors.
    Suzuki T; Khan MN; Sawada H; Imai E; Itoh Y; Yamatsuta K; Tokuda N; Takeuchi J; Seko T; Nakagawa H; Miyata N
    J Med Chem; 2012 Jun; 55(12):5760-73. PubMed ID: 22642300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the near infrared compound indocyanine green as a probe substrate of p-glycoprotein.
    Portnoy E; Gurina M; Magdassi S; Eyal S
    Mol Pharm; 2012 Dec; 9(12):3595-601. PubMed ID: 23098218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, synthesis and antiproliferative activities of novel benzamides derivatives as HDAC inhibitors.
    Li Y; Wang Y; Xie N; Xu M; Qian P; Zhao Y; Li S
    Eur J Med Chem; 2015 Jul; 100():270-6. PubMed ID: 26140961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Periplocymarin is a potential natural compound for drug development: highly permeable with absence of P-glycoprotein efflux and cytochrome P450 inhibitions.
    Martey ON; He X; Xing H; Deng F; Feng S; Li C; Shi X
    Biopharm Drug Dispos; 2014 May; 35(4):195-206. PubMed ID: 24424534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Triazinoindole analogs as potent inhibitors of α-glucosidase: synthesis, biological evaluation and molecular docking studies.
    Rahim F; Ullah K; Ullah H; Wadood A; Taha M; Ur Rehman A; uddin I; Ashraf M; Shaukat A; Rehman W; Hussain S; Khan KM
    Bioorg Chem; 2015 Feb; 58():81-7. PubMed ID: 25528720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of PH-797804, a highly selective and potent inhibitor of p38 MAP kinase.
    Selness SR; Devraj RV; Devadas B; Walker JK; Boehm TL; Durley RC; Shieh H; Xing L; Rucker PV; Jerome KD; Benson AG; Marrufo LD; Madsen HM; Hitchcock J; Owen TJ; Christie L; Promo MA; Hickory BS; Alvira E; Naing W; Blevis-Bal R; Messing D; Yang J; Mao MK; Yalamanchili G; Vonder Embse R; Hirsch J; Saabye M; Bonar S; Webb E; Anderson G; Monahan JB
    Bioorg Med Chem Lett; 2011 Jul; 21(13):4066-71. PubMed ID: 21641211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis, antibacterial activities and molecular docking studies of peptide and Schiff bases as targeted antibiotics.
    Cheng K; Zheng QZ; Qian Y; Shi L; Zhao J; Zhu HL
    Bioorg Med Chem; 2009 Dec; 17(23):7861-71. PubMed ID: 19884012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Synthesis and anti-tumor activities of N-substituted benzamide derivatives].
    Feng J; Xie P; Weng ZJ; Yan Z; Wang N; Li JQ
    Yao Xue Xue Bao; 2009 Jun; 44(6):603-8. PubMed ID: 19806890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclic aromatic oligoamides as highly selective receptors for the guanidinium ion.
    Sanford AR; Yuan L; Feng W; Yamato K; Flowers RA; Gong B
    Chem Commun (Camb); 2005 Oct; (37):4720-2. PubMed ID: 16175304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design, synthesis, enzyme inhibition, and tumor cell growth inhibition of 2-anilinobenzamide derivatives as SIRT1 inhibitors.
    Suzuki T; Imai K; Imai E; Iida S; Ueda R; Tsumoto H; Nakagawa H; Miyata N
    Bioorg Med Chem; 2009 Aug; 17(16):5900-5. PubMed ID: 19616958
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, synthesis and biological evaluation of novel acrylamide analogues as inhibitors of BCR-ABL kinase.
    Li S; Yao Z; Zhao Y; Chen W; Wang H; Kuang X; Zhan W; Yao S; Yu S; Hu W
    Bioorg Med Chem Lett; 2012 Aug; 22(16):5279-82. PubMed ID: 22789429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enaminones 9. Further studies on the anticonvulsant activity and potential type IV phosphodiesterase inhibitory activity of substituted vinylic benzamides.
    Anderson AJ; Nicholson JM; Bakare O; Butcher RJ; Wilson TL; Scott KR
    Bioorg Med Chem; 2006 Feb; 14(4):997-1006. PubMed ID: 16219468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Small P-gp modulating molecules: SAR studies on tetrahydroisoquinoline derivatives.
    Colabufo NA; Berardi F; Cantore M; Perrone MG; Contino M; Inglese C; Niso M; Perrone R; Azzariti A; Simone GM; Porcelli L; Paradiso A
    Bioorg Med Chem; 2008 Jan; 16(1):362-73. PubMed ID: 17936633
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetic interaction profile of riociguat, a new soluble guanylate cyclase stimulator, in vitro.
    Rickert V; Haefeli WE; Weiss J
    Pulm Pharmacol Ther; 2014 Aug; 28(2):130-7. PubMed ID: 24657506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, synthesis and biological evaluation of 6-(benzyloxy)-4-methylquinolin-2(1H)-one derivatives as PDE3 inhibitors.
    Nikpour M; Sadeghian H; Saberi MR; Nick RS; Seyedi SM; Hosseini A; Parsaee H; Bozorg AT
    Bioorg Med Chem; 2010 Jan; 18(2):855-62. PubMed ID: 20005117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design and synthesis of 3-substituted benzamide derivatives as Bcr-Abl kinase inhibitors.
    Asaki T; Sugiyama Y; Hamamoto T; Higashioka M; Umehara M; Naito H; Niwa T
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1421-5. PubMed ID: 16332440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.